Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
Dwan-Ying Chang,1 Wei-Li Ma,1,2 Yen-Shen Lu1 1Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; 2Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, TaiwanCorrespondence: Yen-Shen LuDepartment of Oncology, National Taiwan University Hosp...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f9bbf567c77d45949e2cc7fdf4e7b24a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|